Chronic hepatitis C virus infection and atherosclerosis: Clinical impact and mechanisms

World Journal of Gastroenterology

Volumn 20, Issue 13, 2014, Pages 3410-3417

  Adinolfi, Luigi E ^a   Zampino, Rosa ^a   Restivo, Luciano ^a   Lonardo, Amedeo ^b   Guerrera, Barbara ^a   Marrone, Aldo ^a   Nascimbeni, Fabio ^b   Florio, Anna ^a   Loria, Paola ^b  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

^b UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

Author keywords

Atherosclerosis; Coronary artery disease; Hepatitis C virus; Inflammation; Stroke

Indexed keywords

CYTOKINE; GAMMA INTERFERON; GELATINASE B; INTERFERON; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; RIBAVIRIN; STRUCTURAL PROTEIN; TUMOR NECROSIS FACTOR ALPHA;

ARTERIAL STIFFNESS; ARTICLE; ATHEROSCLEROSIS; BRAIN ISCHEMIA; CARDIOVASCULAR RISK; CAROTID ATHEROSCLEROSIS; CELLULAR IMMUNITY; CEREBROVASCULAR ACCIDENT; CEREBROVASCULAR DISEASE; CORONARY ARTERY DISEASE; CRYOGLOBULINEMIA; ENDOTOXEMIA; FIBROSIS; HEART FAILURE; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMORAL IMMUNITY; HYPERHOMOCYSTEINEMIA; HYPERTENSION; HYPOADIPONECTINEMIA; INFLAMMATION; INSULIN RESISTANCE; META ANALYSIS (TOPIC); METABOLIC SYNDROME X; MIXED INFECTION; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; NONALCOHOLIC FATTY LIVER; OXIDATIVE STRESS; PATHOGENESIS; RISK FACTOR; VASCULAR DISEASE; COMORBIDITY; COMPLICATION; METABOLISM; PREVALENCE; VIROLOGY;

ATHEROSCLEROSIS; COMORBIDITY; CORONARY ARTERY DISEASE; CYTOKINES; HEART FAILURE; HEPATITIS C, CHRONIC; HUMANS; INFLAMMATION; PREVALENCE; RISK FACTORS; STROKE;

EID: 84897475074     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v20.i13.3410     Document Type: Article

References (50)

1. Lauer GM, Walker BD. Hepatitis C virus infection. N Engl J Med 2001; 345: 41-52 [PMID: 11439948 DOI: 10.1056/ NEJM200107053450107]
2. Zignego AL, Craxì A. Extrahepatic manifestations of hepatitis C virus infection. Clin Liver Dis 2008; 12: 611-636, ix [PMID: 18625431 DOI: 10.1016/j.cld.2008.03.012]
3. Adinolfi LE, Restivo L, Zampino R, Lonardo A, Loria P. Metabolic alterations and chronic hepatitis C: treatment strategies. Expert Opin Pharmacother 2011; 12: 2215-2234 [PMID: 21883025 DOI: 10.1517/14656566.2011.597742]
4. Zampino R, Marrone A, Restivo L, Guerrera B, Sellitto A, Rinaldi L, Romano C, Adinolfi LE. Chronic HCV infection and inflammation: Clinical impact on hepatic and extra-hepatic manifestations. World J Hepatol 2013; 5: 528-540 [PMID: 24179612 DOI: 10.4254/wjh.v5.i10.528]
5. Gilbert A, Lion G. Arterites infectieuses experimentales. C R Hebd Seances Soc Biol Fil 1889; 41: 583-584
6. Stassen FR, Vainas T, Bruggeman CA. Infection and atherosclerosis. An alternative view on an outdated hypothesis. Pharmacol Rep 2008; 60: 85-92 [PMID: 18276989]
7. Loria P, Lonardo A, Targher G. Is liver fat detrimental to vessels?: intersections in the pathogenesis of NAFLD and atherosclerosis. Clin Sci (Lond) 2008; 115: 1-12 [PMID: 19016656 DOI: 10.1042/CS20070311]
8. Kadayifci A, Tan V, Ursell PC, Merriman RB, Bass NM. Clinical and pathologic risk factors for atherosclerosis in cirrhosis: a comparison between NASH-related cirrhosis and cirrhosis due to other aetiologies. J Hepatol 2008; 49: 595-599 [PMID: 18662837 DOI: 10.1016/j.jhep.2008.05.024]
9. Adinolfi LE, Restivo L, Marrone A. The predictive value of steatosis in hepatitis C virus infection. Expert Rev Gastroenterol Hepatol 2013; 7: 205-213 [PMID: 23445230 DOI: 10.1586/ egh.13.7]
10. Boddi M, Abbate R, Chellini B, Giusti B, Solazzo V, Soft F, Pratesi G, Pratesi C, Gensini G, Zignego AL. HCV infection facilitates asymptomatic carotid atherosclerosis: preliminary report of HCV RNA localization in human carotid plaques. Dig Liver Dis 2007; 39 Suppl 1: S55-S60 [PMID: 17936225 DOI: 10.1016/S1590-8658(07)80012-0]
11. Boddi M, Abbate R, Chellini B, Giusti B, Giannini C, Pratesi G, Rossi L, Pratesi C, Gensini GF, Paperetti L, Zignego AL. Hepatitis C virus RNA localization in human carotid plaques. J Clin Virol 2010; 47: 72-75 [PMID: 19896417 DOI: 10.1016/j.jcv.2009.10.005]
12. Ishizaka N, Ishizaka Y, Takahashi E, Tooda Ei, Hashimoto H, Nagai R, Yamakado M. Association between hepatitis C virus seropositivity, carotid-artery plaque, and intima-media thickening. Lancet 2002; 359: 133-135 [PMID: 11809259]
13. Ishizaka Y, Ishizaka N, Takahashi E, Unuma T, Tooda E, Hashimoto H, Nagai R, Yamakado M. Association between hepatitis C virus core protein and carotid atherosclerosis. Circ J 2003; 67: 26-30 [PMID: 12520147]
14. Vassalle C, Masini S, Bianchi F, Zucchelli GC. Evidence for association between hepatitis C virus seropositivity and coronary artery disease. Heart 2004; 90: 565-566 [PMID: 15084562]
15. Targher G, Bertolini L, Padovani R, Rodella S, Arcaro G, Day C. Differences and similarities in early atherosclerosis between patients with non-alcoholic steatohepatitis and chronic hepatitis B and C. J Hepatol 2007; 46: 1126-1132 [PMID: 17335930 DOI: 10.1016/j.jhep.2007.01.021]
16. Völzke H, Schwahn C, Wolff B, Mentel R, Robinson DM, Kleine V, Felix SB, John U. Hepatitis B and C virus infection and the risk of atherosclerosis in a general population. Atherosclerosis 2004; 174: 99-103 [PMID: 15135257]
17. Arcari CM, Nelson KE, Netski DM, Nieto FJ, Gaydos CA. No association between hepatitis C virus seropositivity and acute myocardial infarction. Clin Infect Dis 2006; 43: e53-e56 [PMID: 16912934]
18. Guiltinan AM, Kaidarova Z, Custer B, Orland J, Strollo A, Cyrus S, Busch MP, Murphy EL. Increased all-cause, liver, and cardiac mortality among hepatitis C virus-seropositive blood donors. Am J Epidemiol 2008; 167: 743-750 [PMID: 18203734 DOI: 10.1093/aje/kwm370]
19. El-Kamary SS, Jhaveri R, Shardell MD. All-cause, liver-related, and non-liver-related mortality among HCV-infected individuals in the general US population. Clin Infect Dis 2011; 53: 150-157 [PMID: 21665867 DOI: 10.1093/cid/cir306]
20. Tomiyama H, Arai T, Hirose K, Hori S, Yamamoto Y, Yamashina A. Hepatitis C virus seropositivity, but not hepatitis B virus carrier or seropositivity, associated with increased pulse wave velocity. Atherosclerosis 2003; 166: 401-403 [PMID: 12535755]
21. Fukui M, Kitagawa Y, Nakamura N, Yoshikawa T. Hepatitis C virus and atherosclerosis in patients with type 2 diabetes. JAMA 2003; 289: 1245-1246 [PMID: 12633185]
22. Mostafa A, Mohamed MK, Saeed M, Hasan A, Fontanet A, Godsland I, Coady E, Esmat G, El-Hoseiny M, Abdul-Hamid M, Hughes A, Chaturvedi N. Hepatitis C infection and clearance: impact on atherosclerosis and cardiometabolic risk factors. Gut 2010; 59: 1135-1140 [PMID: 20584782 DOI: 10.1136/gut.2009.202317]
23. Petta S, Torres D, Fazio G, Cammà C, Cabibi D, Di Marco V, Licata A, Marchesini G, Mazzola A, Parrinello G, Novo S, Licata G, Craxì A. Carotid atherosclerosis and chronic hepatitis C: a prospective study of risk associations. Hepatology 2012; 55: 1317-1323 [PMID: 22135089 DOI: 10.1002/ hep.25508]
24. Adinolfi LE, Restivo L, Zampino R, Guerrera B, Lonardo A, Ruggiero L, Riello F, Loria P, Florio A. Chronic HCV infection is a risk of atherosclerosis. Role of HCV and HCVrelated steatosis. Atherosclerosis 2012; 221: 496-502 [PMID: 22385985 DOI: 10.1016/j.atherosclerosis.2012.01.051]
25. Durante-Mangoni E, Zampino R, Marrone A, Tripodi MF, Rinaldi L, Restivo L, Cioffi M, Ruggiero G, Adinolfi LE. Hepatic steatosis and insulin resistance are associated with serum imbalance of adiponectin/tumour necrosis factoralpha in chronic hepatitis C patients. Aliment Pharmacol Ther 2006; 24: 1349-1357 [PMID: 17059516 DOI: 10.1111/ j.1365-2036.2006.03114.x]
26. Vidali M, Tripodi MF, Ivaldi A, Zampino R, Occhino G, Restivo L, Sutti S, Marrone A, Ruggiero G, Albano E, Adinolfi LE. Interplay between oxidative stress and hepatic steatosis in the progression of chronic hepatitis C. J Hepatol 2008; 48: 399-406 [PMID: 18164507 DOI: 10.1016/j.jhep.2007.10.011]
27. Sosner P, Wangermez M, Chagneau-Derrode C, Le Moal G, Silvain C. Atherosclerosis risk in HIV-infected patients: the influence of hepatitis C virus co-infection. Atherosclerosis 2012; 222: 274-277 [PMID: 22417840 DOI: 10.1016/j.atheroscl erosis.2012.02.027]
28. Bilora F, Campagnolo E, Rinaldi R, Rossato A, Arzenton M, Petrobelli F. Carotid and femoral atherosclerosis in chronic hepatitis C: a 5-year follow-up. Angiology 2008; 59: 717-720 [PMID: 18388091 DOI: 10.1177/0003319707311536]
29. Caliskan Y, Oflaz H, Pusuroglu H, Boz H, Yazici H, Tamer S, Karsidag K, Yildiz A. Hepatitis C virus infection in hemodialysis patients is not associated with insulin resistance, inflammation and atherosclerosis. Clin Nephrol 2009; 71: 147-157 [PMID: 19203507]
30. Tien PC, Schneider MF, Cole SR, Cohen MH, Glesby MJ, Lazar J, Young M, Mack W, Hodis HN, Kaplan RC. Association of hepatitis C virus and HIV infection with subclinical atherosclerosis in the women's interagency HIV study. AIDS 2009; 23: 1781-1784 [PMID: 19553807 DOI: 10.1097/ QAD.0b013e32832d7aa8]
31. Masiá M, Padilla S, Robledano C, Ramos JM, Gutiérrez F. Evaluation of endothelial function and subclinical atherosclerosis in association with hepatitis C virus in HIV-infected patients: a cross-sectional study. BMC Infect Dis 2011; 11: 265 [PMID: 21967471 DOI: 10.1186/1471-2334-11-265]
32. Lee MH, Yang HI, Lu SN, Jen CL, You SL, Wang LY, Wang CH, Chen WJ, Chen CJ. Chronic hepatitis C virus infection increases mortality from hepatic and extrahepatic diseases: a community-based long-term prospective study. J Infect Dis 2012; 206: 469-477 [PMID: 22811301 DOI: 10.1093/infdis/ jis385]
33. Lee MH, Yang HI, Wang CH, Jen CL, Yeh SH, Liu CJ, You SL, Chen WJ, Chen CJ. Hepatitis C virus infection and increased risk of cerebrovascular disease. Stroke 2010; 41: 2894-2900 [PMID: 20966408 DOI: 10.1161/STROKEAHA.110.598136]
34. Berenguer J, Rodríguez E, Miralles P, Von Wichmann MA, López-Aldeguer J, Mallolas J, Galindo MJ, Van Den Eynde E, Téllez MJ, Quereda C, Jou A, Sanz J, Barros C, Santos I, Pulido F, Guardiola JM, Ortega E, Rubio R, Jusdado JJ, Montes ML, Gaspar G, Esteban H, Bellón JM, González-García J. Sustained virological response to interferon plus ribavirin reduces non-liver-related mortality in patients coinfected with HIV and Hepatitis C virus. Clin Infect Dis 2012; 55: 728-736 [PMID: 22610932 DOI: 10.1093/cid/cis500]
35. Butt AA, Xiaoqiang W, Budoff M, Leaf D, Kuller LH, Justice AC. Hepatitis C virus infection and the risk of coronary disease. Clin Infect Dis 2009; 49: 225-232 [PMID: 19508169 DOI: 10.1086/599371]
36. Forde KA, Haynes K, Troxel AB, Trooskin S, Osterman MT, Kimmel SE, Lewis JD, Lo Re V. Risk of myocardial infarction associated with chronic hepatitis C virus infection: a population- based cohort study. J Viral Hepat 2012; 19: 271-277 [PMID: 22404725 DOI: 10.1111/j.1365-2893.2011.01545.x]
37. Alyan O, Kacmaz F, Ozdemir O, Deveci B, Astan R, Celebi AS, Ilkay E. Hepatitis C infection is associated with increased coronary artery atherosclerosis defined by modified Reardon severity score system. Circ J 2008; 72: 1960-1965 [PMID: 18957787]
38. Yelken B, Gorgulu N, Caliskan Y, Elitok A, Cimen AO, Yazici H, Oflaz H, Turkmen A, Sever MS. Association between chronic hepatitis C infection and coronary flow reserve in dialysis patients with failed renal allografts. Transplant Proc 2009; 41: 1519-1523 [PMID: 19545669 DOI: 10.1016/j.transproceed. 2009.03.069]
39. Maruyama S, Koda M, Oyake N, Sato H, Fujii Y, Horie Y, Murawaki Y. Myocardial injury in patients with chronic hepatitis C infection. J Hepatol 2013; 58: 11-15 [PMID: 22889957 DOI: 10.1016/j.jhep.2012.07.045]
40. Younossi ZM, Stepanova M, Nader F, Younossi Z, Elsheikh E. Associations of chronic hepatitis C with metabolic and cardiac outcomes. Aliment Pharmacol Ther 2013; 37: 647-652 [PMID: 23384408 DOI: 10.1111/apt.12234]
41. Adinolfi LE, Restivo L, Guerrera B, Sellitto A, Ciervo A, Iuliano N, Rinaldi L, Santoro A, Li Vigni G, Marrone A. Chronic HCV infection is a risk factor of ischemic stroke. Atherosclerosis 2013; 231: 22-26 [PMID: 24125405 DOI: 10.1016/j.atherosclerosis.2013.08.003]
42. Forssen U, McAfee A, Enger C, Bennett D, Shantakumar S. Risk of thromboembolic events (TEs) among patients infected with hepatitis C. Hepatology 2009; 50: 672A
43. Gutierrez J, Elkind MSV. Chronic inflammatory diseases and stroke: Evidence for heterogeneous mechanisms. Ann Neurol 2012; 72: S6-S7
44. Liao CC, Su TC, Sung FC, Chou WH, Chen TL. Does hepatitis C virus infection increase risk for stroke? A populationbased cohort study. PLoS One 2012; 7: e31527 [PMID: 22363662 DOI: 10.1371/journal.pone.0031527]
45. Hsu CS, Kao JH, Chao YC, Lin HH, Fan YC, Huang CJ, Tsai PS. Interferon-based therapy reduces risk of stroke in chronic hepatitis C patients: a population-based cohort study in Taiwan. Aliment Pharmacol Ther 2013; 38: 415-423 [PMID: 23802888 DOI: 10.1111/apt.12391]
46. He Huang R, Zhao Z. Hepatitis C virus infection and risk of stroke: a systematic review and meta-analysis. PLoS One 2013; 8: e81305 [PMID: 24265844 DOI: 10.1371/journal. pone.0081305.]
47. Costantini S, Capone F, Guerriero E, Maio P, Colonna G, Castello G. Serum cytokine levels as putative prognostic markers in the progression of chronic HCV hepatitis to cirrhosis. Eur Cytokine Netw 2010; 21: 251-256 [PMID: 21081303 DOI: 10.1684/ecn.2010.0214]
48. Abbas Z, Moatter T. Interleukin (IL) 1beta and IL-10 gene polymorphism in chronic hepatitis C patients with normal or elevated alanine aminotransferase levels. J Pak Med Assoc 2003; 53: 59-62 [PMID: 12705485]
49. Tsui JI, Whooley MA, Monto A, Seal K, Tien PC, Shlipak M. Association of hepatitis C virus seropositivity with inflammatory markers and heart failure in persons with coronary heart disease: data from the Heart and Soul study. J Card Fail 2009; 15: 451-456 [PMID: 19477406 DOI: 10.1016/ j.cardfail.2008.12.003]
50. Oliveira CP, Kappel CR, Siqueira ER, Lima VM, Stefano JT, Michalczuk MT, Marini SS, Barbeiro HV, Soriano FG, Carrilho FJ, Pereira LM, Alvares-da-Silva MR. Effects of hepatitis C virus on cardiovascular risk in infected patients: a comparative study. Int J Cardiol 2013; 164: 221-226 [PMID: 21784542 DOI: 10.1016/j.ijcard.2011.07.016]